Broker Research
November 27, 2025 / 11:56 IST
Reported Standalone quarterly numbers for ANG Lifesciences India are:Net Sales at Rs 25.97 crore in September 2025 down 19.24% from Rs. 32.16 crore in September 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.80 crore in September 2025 up 25.52% from Rs. 1.07 crore in September 2024.
EBITDA stands at Rs. 2.42 crore in September 2025 down 14.18% from Rs. 2.82 crore in September 2024.
ANG Lifescience shares closed at 25.39 on November 26, 2025 (BSE) and has given -12.66% returns over the last 6 months and -43.58% over the last 12 months.
| ANG Lifesciences India | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 25.97 | 24.53 | 32.16 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 25.97 | 24.53 | 32.16 | | EXPENDITURE | | Consumption of Raw Materials | 17.01 | 16.45 | 24.18 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.57 | -0.25 | -2.42 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.86 | 3.49 | 3.79 | | Depreciation | 1.45 | 1.45 | 1.62 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 3.45 | 2.99 | 4.15 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.76 | 0.41 | 0.84 | | Other Income | 0.21 | 0.17 | 0.36 | | P/L Before Int., Excpt. Items & Tax | 0.97 | 0.58 | 1.20 | | Interest | 1.59 | 1.61 | 1.87 | | P/L Before Exceptional Items & Tax | -0.62 | -1.03 | -0.67 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.62 | -1.03 | -0.67 | | Tax | 0.18 | -0.24 | 0.41 | | P/L After Tax from Ordinary Activities | -0.80 | -0.79 | -1.07 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.80 | -0.79 | -1.07 | | Equity Share Capital | 13.06 | 13.06 | 13.06 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.60 | -0.59 | -0.75 | | Diluted EPS | -0.60 | -0.59 | -0.75 | | EPS After Extra Ordinary | | Basic EPS | -0.60 | -0.59 | -0.75 | | Diluted EPS | -0.60 | -0.59 | -0.75 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
